Cellectis’ Meganuclease Technology Used to Efficiently Prevent Viral Infection
21-Jan-2011 -
Cellectis announced that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1). The research ...
herpes simplex
meganucleases